Exosomes from human umbilical cord mesenchymal stem cells (hucMSC-Ex) have been
suggested as novel nanomaterials for regenerative medicine. Here we explored the roles of …

Extracellular vesicles (EVs) that are derived from mesenchymal stromal cells (MSCs) have
been shown to reprogram injured cells by activating regenerative processes. We herein …

Background: Mesenchymal stromal cells (MSCs) derived extracellular vesicles (EVs) were
regarded as a potent medium for kidney injury repair and angiogenesis were regarded as …

Hypoxia is associated with tissue injury and fibrosis but its functional role in fibroblast
activation and tissue repair/regeneration is unknown. Using kidney injury as a model …

Abstract Introduction Microparticles (MPs) derived from kidney-derived mesenchymal stem
cells (KMSCs) have recently been reported to ameliorate rarefaction of peritubular …

Mesenchymal stem/stromal cells (MSCs) are the most utilized cell type for cellular therapy,
partly due to their important proliferative potential and ability to differentiate into various cell …

Extracellular vesicles (EVs) released by mesenchymal stem cells (MSCs) have exhibited
regenerative capability in animal models of ischemia–reperfusion (I/R) acute kidney injury …

Current studies suggest that mesenchymal stromal cells (MSCs) improve acute kidney injury
(AKI) via paracrine/endocrine effects. We established human adipose tissue-derived stromal …

Renal ischemia/reperfusion (I/R) injury is the main reason for acute kidney injury (AKI) and is
closely related to high morbidity and mortality. In this study, we found that exosomes from …

Mesenchymal stem cell (MSC)-derived exosomes have been recognized as new candidates
for the treatment of degenerative diseases or injury and may provide an alternative to cell …